ExpressCells Revenue and Competitors
Estimated Revenue & Valuation
- ExpressCells's estimated annual revenue is currently $310k per year.
- ExpressCells's estimated revenue per employee is $155,000
Employee Data
- ExpressCells has 2 Employees.
- ExpressCells grew their employee count by -78% last year.
ExpressCells's People
Name | Title | Email/Phone |
---|---|---|
1 | Scientific Director | Reveal Email/Phone |
2 | Financial Consultant | Reveal Email/Phone |
ExpressCells Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $1.6M | 10 | 0% | N/A | N/A |
#2 | $4M | 26 | 13% | N/A | N/A |
#3 | $0.9M | 6 | -14% | N/A | N/A |
#4 | $1.1M | 7 | 0% | N/A | N/A |
#5 | $10.9M | 70 | 3% | N/A | N/A |
#6 | $0.7M | 9 | 29% | N/A | N/A |
#7 | $4M | 26 | -16% | N/A | N/A |
#8 | $1.7M | 11 | 22% | N/A | N/A |
#9 | $7.6M | 49 | 2% | N/A | N/A |
#10 | $1.6M | 10 | 0% | N/A | N/A |
What Is ExpressCells?
Biological researchers need to identify how new drugs and biologics works within cells. To do so, they test these products in cell lines: human cells propagated in lab culture. These cell lines are often genetically altered in order to study a specific protein but current processes take 4-6 months, the modifications are limited, and altered cells are often killed in order to study the protein of interest. ExpressCells has a superior technology that does not have these limitations. We use CRISPR plus our proprietary genetic vector system to create custom cells for research 4X faster. Our living cells can replicate diseases or have proteins glow in multiple colors. Learn more by following us on Twitter at https://twitter.com/expresscells
keywords:N/AN/A
Total Funding
2
Number of Employees
$310k
Revenue (est)
-78%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $0.2M | 2 | -67% | N/A |
#2 | $0.2M | 2 | -60% | N/A |
#3 | $0.1M | 2 | 0% | N/A |
#4 | $0M | 2 | -50% | N/A |
#5 | N/A | 2 | -93% | N/A |